EM

Emerging Microbes & Infections

Emerging Microbes & Infections is a peer-reviewed open access journal publishing research on emerging infections. It covers epidemic surveillance, clinical manifestation, diagnosis and management, cellular and molecular pathogenesis, immune responses, drug discovery, and vaccine development research.

Looking to publish in Emerging Microbes & Infections? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Infectious Diseases
Impact Factor 7.5
Quartile Q1
Open Access Type Open
eISSN 2222-1751
Invitation Only No
Cost Range Article Publishing Charge (APC) may be required for open access publication; reduced or waived APC may be available through agreements, memberships, discounts, or waivers.

Submission Instructions

Emerging Microbes & Infections accepts the following article types. Click on an article type to view submission instructions.

Original Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. The abstract must be 250 words. The abstract must be unstructured.
Manuscript The manuscript must be no more than 6,000 words inclusive of the abstract, tables, references, figure or table captions, and footnotes. The manuscript must be ordered as title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. The manuscript must include 5 to 8 keywords and a declaration of interest statement.
References The manuscript must cite no more than 60 references. References must use NLM style.
Figures & Tables The manuscript must contain no more than 8 display items. Figures must be saved separately from the text. Tables must be supplied as editable files.
Reformat to Emerging Microbes & Infections using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Review Articles must include an abstract. The abstract must be 250 words. The abstract must be unstructured.
Manuscript Review Articles must not exceed 6,000 words inclusive of the abstract, tables, references, figure or table captions, and footnotes. Review Articles must be arranged in the following order: title page, abstract, keywords, main text introduction, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Review Articles must include 5 to 8 keywords and may be structured using short topical headings.
References Review Articles must cite no more than 80 references. References must use NLM style.
Figures & Tables Review Articles must contain no more than 8 display items. Figures must be saved separately from the text. Tables must be supplied as editable files.
Reformat to Emerging Microbes & Infections using Livewrite Premium

Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include funding details and a disclosure statement under the subheading “Disclosure of interest.”
References References must use NLM reference style.
Figures & Tables Figures must be saved separately from the text. Tables must be supplied as editable files and should present new information that is interpretable without reference to the text.
Reformat to Emerging Microbes & Infections using Livewrite Premium

Letters

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript The manuscript must include funding details and a disclosure statement under the subheading “Disclosure of interest.”
References References must use NLM reference style.
Figures & Tables Figures must be saved separately from the text. Tables must be supplied as editable files.
Reformat to Emerging Microbes & Infections using Livewrite Premium

Research Letter

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Research Letter submissions must be no more than 1,500 words, inclusive of tables, references, figure or table captions, and footnotes. Research Letter submissions must be ordered as title page, main text and discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. The manuscript must include acknowledgments and a declaration of interest statement.
References Research Letter submissions must cite no more than 15 references. References must use the NLM reference style.
Figures & Tables Research Letter submissions must contain no more than 1 display item. Figures must be saved separately from the text. Tables must be supplied as editable files.
Reformat to Emerging Microbes & Infections using Livewrite Premium

Recent Publications

Correction

-

10.1080/22221751.2026.2678031
View Publication

Hantavirus seroprevalence and associated factors for exposure in south-central Uganda  

Gerald Katushabe, Victor Ssempijja, Deepashri Rao, Josephine Nalwadda, Kyle Rosenke, Steven J. Reynolds, Jonah Omooja, Irene Andia Biraro, Mary K. Grabowski, Evan A. Mihalakakos, Ronald M. Galiwango, Robert Ssekubugu, Denis K. Byarugaba, Heinz Feldmann, David W. Hawman

10.1080/22221751.2026.2665002
View Publication

Evaluation of candidate reference materials for the harmonization of Lassa fever serology

Emma M. Bentley, Ndapewa Ithete, Jane Mitchell, Samuel A.S. Richardson, Valentina Bernasconi, Marian Killip, Robert F. Garry, Luis Branco, Stephan Günther, Eleanor Atkinson, Peter Rigsby, Mette Hinrichs, Lisa Oestereich, Anke Thielebein, Valentine Omoifo, Racheal Omiunu, Rita Esumeh, Sylvanus Okogbenin, Paul A. Kristiansen, Mark Page, Ephraim Ogbaini-Emovon, Giada Mattiuzzo

10.1080/22221751.2026.2640285
View Publication

Development of a novel hybrid alphavirus-Nipah virus pseudovirion for rapid quantification of vaccine-induced neutralization antibodies

Brian Hetrick, Sravya Sowdamini Nakka, Dongyang Yu, Sarah Swineford, Nadia Storm, Anthony Griffiths, Yuntao Wu

10.1080/22221751.2026.2660425
View Publication

Detection of a Merbecovirus with potential ACE2 usage in France

Océane Rieu, Stéphane Descorps-Declère, Anaïs Dufau, Jordan Meliani, Lionel Brazier, Marion Vittecoq, Carole Leray, Anthony Olivier, Illich Mombo, Frédéric Thomas, Eric M. Leroy, Nicolas Berthet

10.1080/22221751.2026.2651469
View Publication

Frequently asked questions

How long does it take to publish?

30 days to first decision; 38 days to first post-review decision; 20 days from acceptance to online publication.

Reformat to Emerging Microbes & Infections using Livewrite Premium

What are the publication costs?

An Article Publishing Charge (APC) may be required for open access publication.

Reformat to Emerging Microbes & Infections using Livewrite Premium

Research Topics

SARS-CoV-2 and COVID-19 Research Viral Infections and Vectors Viral gastroenteritis research and epidemiology Influenza Virus Research Studies Mosquito-borne diseases and control Animal Disease Management and Epidemiology COVID-19 Clinical Research Studies Respiratory viral infections research Animal Virus Infections Studies Viral Infections and Immunology Research Antibiotic Resistance in Bacteria Viral Infections and Outbreaks Research SARS-CoV-2 detection and testing Tuberculosis Research and Epidemiology Hepatitis B Virus Studies Mycobacterium research and diagnosis HIV Research and Treatment Malaria Research and Control Vector-Borne Animal Diseases Virology and Viral Diseases Virus-based gene therapy research Vector-borne infectious diseases COVID-19 epidemiological studies Vibrio bacteria research studies Pneumonia and Respiratory Infections

Related Journals

HM
Hiv Medicine WILEY
Al
Allergy WILEY
TA
Transboundary And Emerging Diseases WILEY
JO
Journal Of Autoimmunity Elsevier BV
JO
Journal Of Infection And Public Health Elsevier BV
AP
Aids Patient Care And Stds Mary Ann Liebert, Inc.